Psychedelic safety is often discussed after something goes wrong. But in responsible clinical care, safety begins much earlier, with screening, preparation, support, and humility.

Ibogaine may hold promise in addiction research, but it also carries serious medical risks and deep cultural roots. Dr. McCall explores why hope, safety, and respect must stay connected.

Follow along as Dr. McCall explores why psychedelic-assisted therapy is far more than the drug – and why the therapy component, from preparation through integration, may be where lasting change actually happens.

What makes one psychedelic experience profound and another frightening, even at the same dose of the same compound? Often it comes down to two words: set and setting. Follow along as Dr. McCall explores why mindset and environment may matter more than the medicine itself – and how indigenous traditions understood this long before the research did.